Vistagen Therapeutics Statistics
Total Valuation
VTGN has a market cap or net worth of $9.55 million. The enterprise value is -$34.81 million.
| Market Cap | 9.55M |
| Enterprise Value | -34.81M |
Important Dates
The next estimated earnings date is Monday, August 10, 2026, after market close.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VTGN has 41.03 million shares outstanding. The number of shares has increased by 23.31% in one year.
| Current Share Class | 41.03M |
| Shares Outstanding | 41.03M |
| Shares Change (YoY) | +23.31% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 0.47% |
| Owned by Institutions (%) | 27.08% |
| Float | 35.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.53 |
| Forward PS | 14.33 |
| PB Ratio | 0.26 |
| P/TBV Ratio | 0.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.67, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.67 |
| Quick Ratio | 3.55 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -131.59% and return on invested capital (ROIC) is -83.12%.
| Return on Equity (ROE) | -131.59% |
| Return on Assets (ROA) | -67.84% |
| Return on Invested Capital (ROIC) | -83.12% |
| Return on Capital Employed (ROCE) | -201.64% |
| Weighted Average Cost of Capital (WACC) | 5.79% |
| Revenue Per Employee | $30,951 |
| Profits Per Employee | -$1.70M |
| Employee Count | 41 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VTGN has paid $7,000 in taxes.
| Income Tax | 7,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.44% in the last 52 weeks. The beta is 0.40, so VTGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -92.44% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 1.44 |
| Relative Strength Index (RSI) | 32.25 |
| Average Volume (20 Days) | 4,243,037 |
Short Selling Information
The latest short interest is 1.60 million, so 3.89% of the outstanding shares have been sold short.
| Short Interest | 1.60M |
| Short Previous Month | 1.59M |
| Short % of Shares Out | 3.89% |
| Short % of Float | 4.56% |
| Short Ratio (days to cover) | 0.36 |
Income Statement
In the last 12 months, VTGN had revenue of $1.27 million and -$69.69 million in losses. Loss per share was -$1.83.
| Revenue | 1.27M |
| Gross Profit | 1.27M |
| Operating Income | -72.13M |
| Pretax Income | -69.68M |
| Net Income | -69.69M |
| EBITDA | -71.93M |
| EBIT | -72.13M |
| Loss Per Share | -$1.83 |
Balance Sheet
The company has $45.40 million in cash and $1.04 million in debt, with a net cash position of $44.36 million or $1.08 per share.
| Cash & Cash Equivalents | 45.40M |
| Total Debt | 1.04M |
| Net Cash | 44.36M |
| Net Cash Per Share | $1.08 |
| Equity (Book Value) | 35.52M |
| Book Value Per Share | 0.90 |
| Working Capital | 34.15M |
Cash Flow
In the last 12 months, operating cash flow was -$66.44 million and capital expenditures -$151,000, giving a free cash flow of -$66.59 million.
| Operating Cash Flow | -66.44M |
| Capital Expenditures | -151,000 |
| Depreciation & Amortization | 199,000 |
| Net Borrowing | 95,000 |
| Free Cash Flow | -66.59M |
| FCF Per Share | -$1.62 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -5,683.69% |
| Pretax Margin | -5,490.78% |
| Profit Margin | n/a |
| EBITDA Margin | -5,668.01% |
| EBIT Margin | -5,683.69% |
| FCF Margin | n/a |
Dividends & Yields
VTGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.31% |
| Shareholder Yield | -23.31% |
| Earnings Yield | -729.51% |
| FCF Yield | -697.07% |
Analyst Forecast
The average price target for VTGN is $1.00, which is 329.55% higher than the current price. The consensus rating is "Hold".
| Price Target | $1.00 |
| Price Target Difference | 329.55% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 150.72% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 7, 2023. It was a reverse split with a ratio of 1:30.
| Last Split Date | Jun 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
VTGN has an Altman Z-Score of -14.24 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.24 |
| Piotroski F-Score | 2 |